Trump to End Medicare Drug Plan Subsidies
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Trump administration will end subsidies for private Medicare drug plans, likely resulting in higher premiums for some older adults right before the midterm elections.
- Democrats were already campaigning on approximately $1 trillion in health care cuts in Republicans' tax bill from last summer and immediately seized the subsidy decision as another affordability attack line.
- Chuck Schumer (D-N.Y.) called the decision "heartless, cruel, and completely by choice."
Why it matters: Older adults enrolled in private Medicare drug plans face likely premium increases timed to the midterm election cycle, while Democrats gain a fresh rallying point on top of the roughly $1 trillion in Republican health care cuts they were already attacking.
